Ipratropium Bromide Solution
Product Images NDC 65862-905

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 65862-905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ipratropium Fig1)

An instructional illustration depicting the process of filling a small medicine nebulizer cup with solution from a vial or ampule. One hand holds the nebulizer mouthpiece connected to the cup, while the other hand positions the vial to dispense liquid into the cup's reservoir, demonstrating preparation for respiratory inhalation treatment.*

FDA Label Image

Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))

The packaging label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) by Aurobindo Pharma Limited. It shows that the product is for oral inhalation only, not for injection, and contains 60 sterile unit dose vials of 2.5 mL (2 x 30 vial pouches). The label includes storage instructions, ingredient details, and distributor information from Aurobindo Pharma USA, Inc.*

FDA Label Image

Figure 2 (Ipratropium Fig2)

An instructional diagram showing a hand holding a respiratory inhalation device and another hand holding a swab or cotton applicator approaching the device's mouthpiece, likely demonstrating cleaning or maintenance steps for the ipratropium bromide inhalation solution device.*

FDA Label Image

Figure 3 (Ipratropium Fig3)

An instructional illustration showing a person using a respiratory inhalation device with a mouthpiece. The figure depicts hand positioning and usage technique for inhaling medication through the device, likely related to administering Ipratropium bromide inhalation solution.*

FDA Label Image

Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))

Label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) sterile unit dose vial by Aurobindo Pharma Limited. It is an oral inhalation solution for respiratory use, presented in a 1 x 2.5 mL vial. The label includes storage instructions, pharmacist attention note, distributor information, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))

Label for Ipratropium Bromide 0.02% (0.5 mg/2.5 mL) inhalation solution by Aurobindo Pharma USA, Inc. The label indicates the product is for oral inhalation only, provided as 25 sterile unit dose vials of 2.5 mL each. It includes storage instructions and distributor information, with the Aurobindo logo at the bottom.*

FDA Label Image

Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))

Label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) by Aurobindo Pharma Limited. The label indicates the product is for oral inhalation only and comes in 30 sterile unit dose vials of 2.5 mL each. It includes storage instructions, distributor information, and a barcode.*

FDA Label Image

Package Label.principal Display Panel (0.02% (0.5 mg/2.5 mL))

Label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) by Aurobindo Pharma Limited. The label states it is for oral inhalation only, not injection, with 2.5 mL sterile unit dose vials, 30 individually wrapped vials per package. It includes storage instructions and manufacturing details.*

FDA Label Image

Package Label.principal Display Panel (0.02% (0.5 mg/2.5 mL))

Label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) by Aurobindo Pharma Limited. The label indicates the product is for oral inhalation only, not for injection, and comes in a package of 25 sterile unit dose vials of 2.5 mL each. It includes storage instructions and pharmacist dispensing information. The NDC is 65862-905-25.*

FDA Label Image

Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))

Packaging label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) by Aurobindo Pharma USA, Inc. The label states it is for oral inhalation only and not for injection. The package contains 30 sterile unit dose vials of 2.5 mL each. Storage instructions, ingredient details, and distributor information are also visible.*

FDA Label Image

Ipratropium Bromide Monohydrate Chemical Structure (Ipratropium Str)

Chemical structure of ipratropium bromide monohydrate, showing the molecular formula C20H30BrNO3·H2O and molecular weight 430.4. The structure includes its bromide and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.